Colgate-Palmolive Company (NYSE:CL) stock traded lower Friday after the consumer-products company reported second-quarter 2026 results.
Adjusted earnings and revenue beat expectations, but weakness in North America and increased tariff headwinds pressured investor sentiment.
Earnings And Margins Base Business EPS rose 8% to 99 cents, beating the 95-cent estimate.
Net sales increased 4.9% to $5.361 billion, above the $5.358 billion estimate, while organic sales grew 2.4%.
The organic result included a 0.4-percentage-point drag from the private-label pet food exit.
